Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-000939
Filing Date
2020-01-10
Accepted
2020-01-10 13:47:02
Documents
3
Period of Report
2020-01-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6442
2 EX-99.1 DOCUMENT attachment1.htm EX-99.1 593
3 EX-99.2 DOCUMENT attachment2.htm EX-99.2 924
  Complete submission text file 0000899243-20-000939.txt   10326
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Reporting) CIK: 0000059478 (see all company filings)

State of Incorp.: IN | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36668 | Film No.: 20520444
SIC: 2834 Pharmaceutical Preparations

Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Issuer) CIK: 0001557883 (see all company filings)

EIN.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELI LILLY & COMPANY LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Business Address C/O ELI LILLY & COMPANY LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 317-276-2000
Bald Eagle Acquisition Corp (Reporting) CIK: 0001799399 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36668 | Film No.: 20520443